日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Monocyte-lineage tumor infiltration predicts immunoradiotherapy response in advanced pretreated soft-tissue sarcoma: phase 2 trial results

单核细胞谱系肿瘤浸润可预测晚期既往接受过治疗的软组织肉瘤的免疫放射治疗反应:II期临床试验结果

Levy, Antonin; Morel, Daphné; Texier, Matthieu; Rodriguez-Ruiz, Maria E; Bouarroudj, Lisa; Bouquet, Fanny; Bustillos, Alberto; Quevrin, Clément; Clémenson, Céline; Mondini, Michele; Meziani, Lydia; Sun, Roger; Zaghdoud, Nadia; Tselikas, Lambros; Assi, Tarek; Faron, Matthieu; Honoré, Charles; Ngo, Carine; Verret, Benjamin; Le Péchoux, Cécile; Le Cesne, Axel; Ginhoux, Florent; Massard, Christophe; Bahleda, Rastilav; Deutsch, Eric

Reshaping the tumor microenvironment of cold soft-tissue sarcomas with anti-angiogenics: a phase 2 trial of regorafenib combined with avelumab

利用抗血管生成药物重塑冷软组织肉瘤的肿瘤微环境:瑞戈非尼联合阿维鲁单抗的 II 期临床试验

Toulmonde, Maud; Guégan, Jean-Philippe; Spalato-Ceruso, Mariella; Valentin, Thibaud; Bahleda, Rastilav; Peyraud, Florent; Rey, Christophe; Kind, Michèle; Cantarel, Coralie; Bellera, Carine; Vanhersecke, Lucile; Bessede, Alban; Italiano, Antoine

Association of Lung Immune Prognostic Index (LIPI) with Disease Control Rate and Progression-Free Survival in Patients with Soft-Tissue Sarcoma Treated with Immunotherapy in Early-Phase Trials

肺免疫预后指数(LIPI)与接受免疫疗法治疗的软组织肉瘤患者的疾病控制率和无进展生存期的相关性(早期试验)

Zoghbi, Marianne; Patel, Brina A; Roulleaux Dugage, Matthieu; Mezquita, Laura; Bahleda, Rastilav; Dufresne, Armelle; Brahmi, Mehdi; Ray-Coquard, Isabelle; Pautier, Patricia; Blay, Jean-Yves; Le Cesne, Axel; Massard, Christophe; Besse, Benjamin; Auclin, Edouard; Nassif Haddad, Elise F

A Phase I Study of KIN-3248, an Irreversible Small-molecule Pan-FGFR Inhibitor, in Patients with Advanced FGFR2/3-driven Solid Tumors

一项针对晚期 FGFR2/3 驱动型实体瘤患者的 I 期研究,评估不可逆小分子泛 FGFR 抑制剂 KIN-3248 的疗效

Garmezy, Benjamin; Borad, Mitesh J; Bahleda, Rastilav; Perez, Cesar A; Chen, Li-Tzong; Kato, Shumei; Oh, Do-Youn; Severson, Paul; Tam, Betty Y; Quah, Cheng S; Harding, James J

Sustained cancer clinical trial activity in a French hospital during the first wave of the COVID-19 pandemic

在新冠肺炎疫情第一波期间,法国一家医院持续开展癌症临床试验活动

Bayle, Arnaud; Baldini, Capucine; Martin-Romano, Patricia; Michot, Jean-Marie; Champiat, Stéphane; Bahleda, Rastilav; Gazzah, Anas; Marabelle, Aurélien; Verlingue, Loic; Geraud, Arthur; Morel, Daphné; Michiels, Stefan; Hollebecque, Antoine; Albiges, Laurence; Besse, Benjamin; Soria, Jean-Charles; Massard, Christophe; Barlesi, Fabrice; Postel-Vinay, Sophie

Patterns of progression in patients treated for immuno-oncology antibodies combination

接受免疫肿瘤抗体联合治疗的患者的疾病进展模式

Bernard-Tessier, Alice; Baldini, Capucine; Castanon, Eduardo; Martin, Patricia; Champiat, Stéphane; Hollebecque, Antoine; Postel-Vinay, Sophie; Varga, Andreea; Bahleda, Rastilav; Gazzah, Anas; Michot, Jean-Marie; Ribrag, Vincent; Armand, Jean-Pierre; Marabelle, Aurélien; Soria, Jean-Charles; Massard, Christophe; Ammari, Samy

Dose escalation phase 1 study of radiotherapy in combination with anti-cytotoxic-T-lymphocyte-associated antigen 4 monoclonal antibody ipilimumab in patients with metastatic melanoma

转移性黑色素瘤患者接受放射治疗联合抗细胞毒性T淋巴细胞相关抗原4单克隆抗体伊匹木单抗的剂量递增I期研究

Boutros, Celine; Chaput-Gras, Nathalie; Lanoy, Emilie; Larive, Alicia; Mateus, Christine; Routier, Emilie; Sun, Roger; Tao, Yun Gan; Massard, Christophe; Bahleda, Rastilav; Schwob, Dominique; Ibrahim, Nathalie; Khoury Abboud, Rita Maria; Caramella, Caroline; Lancia, Andrea; Cassard, Lydie; Roy, Severine; Soria, J-C; Robert, Caroline; Deutsch, Eric

Radiomics to predict outcomes and abscopal response of patients with cancer treated with immunotherapy combined with radiotherapy using a validated signature of CD8 cells

利用经验证的CD8细胞特征,通过放射组学预测接受免疫疗法联合放疗的癌症患者的预后和远隔效应。

Sun, Roger; Sundahl, Nora; Hecht, Markus; Putz, Florian; Lancia, Andrea; Rouyar, Angela; Milic, Marina; Carré, Alexandre; Battistella, Enzo; Alvarez Andres, Emilie; Niyoteka, Stéphane; Romano, Edouard; Louvel, Guillaume; Durand-Labrunie, Jérôme; Bockel, Sophie; Bahleda, Rastilav; Robert, Charlotte; Boutros, Celine; Vakalopoulou, Maria; Paragios, Nikos; Frey, Benjamin; Soria, Jean-Charles; Massard, Christophe; Ferté, Charles; Fietkau, Rainer; Ost, Piet; Gaipl, Udo; Deutsch, Eric

Diverse Resistance Mechanisms to the Third-Generation ALK Inhibitor Lorlatinib in ALK-Rearranged Lung Cancer

ALK重排肺癌对第三代ALK抑制剂劳拉替尼的多种耐药机制

Gonzalo Recondo ,Laura Mezquita ,Francesco Facchinetti ,David Planchard ,Anas Gazzah ,Ludovic Bigot ,Ahsan Z Rizvi ,Rosa L Frias ,Jean Paul Thiery ,Jean-Yves Scoazec ,Tony Sourisseau ,Karen Howarth ,Olivier Deas ,Dariia Samofalova ,Justine Galissant ,Pauline Tesson ,Floriane Braye ,Charles Naltet ,Pernelle Lavaud ,Linda Mahjoubi ,Aurélie Abou Lovergne ,Gilles Vassal ,Rastilav Bahleda ,Antoine Hollebecque ,Claudio Nicotra ,Maud Ngo-Camus ,Stefan Michiels ,Ludovic Lacroix ,Catherine Richon ,Nathalie Auger ,Thierry De Baere ,Lambros Tselikas ,Eric Solary ,Eric Angevin ,Alexander M Eggermont ,Fabrice Andre ,Christophe Massard ,Ken A Olaussen ,Jean-Charles Soria ,Benjamin Besse ,Luc Friboulet

Efficacy of histology-agnostic and molecularly-driven HER2 inhibitors for refractory cancers

组织学无关且分子驱动的HER2抑制剂对难治性癌症的疗效

Cabel, Luc; Fuerea, Alina; Lacroix, Ludovic; Baldini, Capucine; Martin, Patricia; Hollebecque, Antoine; Postel-Vinay, Sophie; Varga, Andrea; Balheda, Rastilav; Gazzah, Anas; Michot, Jean-Marie; Marabelle, Aurélien; Rouleau, Etienne; Solary, Eric; De Baere, Thierry; Angevin, Eric; Armand, Jean-Pierre; Michiels, Stefan; Scoazec, Jean Yves; Ammari, Samy; André, Fabrice; Soria, Jean-Charles; Massard, Christophe; Verlingue, Loic